CB

CBAK Energy Technology Limited

CBATIndustrialsNASDAQ

Electrical Equipment & Parts · Last scanned Oct 22, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$195.2M
+10.5% YoY
Net Income
-$9.4M
-179.5% YoY
EBITDA
-$8.1M
-143.0% YoY
Free Cash Flow
$38.7M

Scan Results

Daily timeframe
2 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 9▼ MACD Negative CrossoverHistogram -0.0371, negative momentum
Oct 8▼ MACD Negative CrossoverHistogram -0.0269, negative momentum
About CBAK Energy Technology Limited

CBAK Energy Technology Limited, together with its subsidiaries, manufactures, commercializes, and distributes lithium-ion and sodium-ion rechargeable batteries. The $74.9M market capitalization puts CBAT squarely in micro-cap range for its industry. The company operates through the CBAK and Hitrans segments.

Where CBAT stands vs its 150-day and 200-day moving averages

As of the October 9, 2026 close, CBAT finished 29.63% above its 150-day moving average ($0.81) and 26.51% above its 200-day moving average ($0.83). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is CBAT overbought or oversold?

At the October 9, 2026 close, CBAT's RSI(14) was 48.1, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$74.9M
Fwd P/E2.56
EPS$-0.18
Beta1.36
52W Change-12.5%
Dividend Yield0.00%
ROE-16.2%
Analysis

The company holds $9.4M in cash, though total debt stands at $51.0M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $38.7M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of -16.2% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has pulled back from $248.7M (2022) to $195.2M (2025), a 22% decline worth watching.

Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CBAT.

Links
More Industrials stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms